The stock surged 13% to Rs 434 on the BSE in morning trade after the company said it has received EIR from the US health regulator for it's both facilities located at Raichur, Karnataka. Shares of Shilpa Medicare have surged by 13% to Rs 434 per share on the BSE in morning trade after the company said that it has received Establishment Inspection Report (EIR) from the US health regulator for both of its facilities located at Raichur, Karnataka. “Our both active pharmaceutical ingredient (API) manufacturing facilities located at Raichur, Karnataka, received EIR from the US Food and Drug Administration (US FDA),” Shilpa Medicare said in a regulatory filing.
To Get Free Trial
Missed call @ 9582541010
Call Us @ 8822117117
Mail Us = starindiamarket@gmail.com
Visit = http://www.starindiaresearch.com/freetrail.php
To Get Free Trial
Missed call @ 9582541010
Call Us @ 8822117117
Mail Us = starindiamarket@gmail.com
Visit = http://www.starindiaresearch.com/freetrail.php
No comments:
Post a Comment